Practice 02 · Africa market entry
Enter with structure. Grow with discipline.
Africa market entry advisory is structured guidance for international operators deciding where, when and with whom to enter or scale in African markets. It replaces continental averages with country-level evidence, treats partner selection as a governance decision rather than a procurement one, and stays with the client through the first phase of execution. It is for chemical, pharmaceutical and energy groups whose board has approved a direction and now needs it to hold on the ground.
African markets carry real growth and real complexity in equal measure. The demographics are well understood at board level, and they are not the variables that decide whether an entry succeeds.
Most entry strategies are sound on paper and drift in execution. They are defeated by the distance between what is decided in the boardroom and what holds on the ground: partner selections that do not survive eighteen months, licensing realities priced as line items rather than gating risks, distribution economics that look different in Lagos or Nairobi than in the entry model, and an operating environment whose informal rules outweigh its formal ones.
Anglophone West Africa, Francophone West Africa, East Africa and Southern Africa are four distinct commercial systems with different regulators, competitive structures and partner ecosystems. A strategy that works in Kenya does not translate to Nigeria, and one calibrated to South Africa rarely survives Ghana.
Three pressures converge on the executive sponsoring entry: a board expecting delivery on the demographic thesis, a shortage of advisors with genuine on-the-ground experience, and a sector record of capital deployed and quietly withdrawn three years later. The cost of getting it wrong is not only the write-down. It is the years lost before the next attempt is credible.
The continent is routinely treated as a single market. It is not.
Source: DJC entry-assumption review, applied across West, Central and East African markets.
We do not produce market reports. We bring the operator’s discipline to the decisions that determine whether entry holds: where, with whom, under what governance, and on what timeline.
01
We test the underlying assumptions — market size, addressable demand, competitive structure, regulatory pathway — country by country and segment by segment, replacing continental aggregates with the specifics that determine whether the model works.
02
Local partners are the single most common point of failure. We bring discipline to how candidates are identified, evaluated against operating and compliance criteria, and engaged under terms that protect the principal’s position over time, not only at signing.
03
Licensing, registration, compliance, taxation, repatriation and employment are not back-office details to resolve after entry. We surface them as gating risks before capital is committed, and design the entry vehicle and timeline around them.
04
We work alongside the internal team through the first phase of execution — partner onboarding, regulatory milestones, first commercial deployments — so boardroom decisions hold under ground conditions. The objective is an operation that survives our departure from it.
Exhibit 1
Where entries drift: the distance between board approval and the first operating quarter.
Phase 01
The growth case is signed off on continental demographics and a target market.
Phase 02
Entry mode, vehicle and timeline are set — usually before regulatory sequencing is tested.
Phase 03 · drift
Partner selection, registration and local content meet the ground. Most schedules and margins move here.
Phase 04
Commercial deployment against a plan the board still recognizes — or does not.
Source: DJC entry-assumption review, applied across West, Central and East African markets.
The output is not a deck. It is an entry that holds.
Calibrated to the specific market rather than the continental story, and defensible to a board that will revisit it in eighteen months.
Selected, contracted and governed against the criteria that matter three years in, not three months in.
Surfaced as gating items before commitment rather than discovered after it.
From board approval to first commercial milestone, without the drift that defeats most entries between the two.
The difference between capital that compounds and capital that quietly leaves the continent.
Short answers to the questions that open most conversations. The full set sits on the FAQ page.
Q
International operators in chemicals, pharmaceuticals and energy with a board-level interest in African growth — entering a first market, restructuring an underperforming position, or scaling one that works.
Q
Earlier than most clients think. The most costly drift happens between board approval and the first operating quarter, so the governance and operating model should be designed alongside the strategy rather than after it.
Q
A country-level entry thesis with tested assumptions, a partner selection and governance structure, a regulatory sequence with gating milestones, and an execution plan with named accountabilities the internal team can run.
Q
Pan-continental experience, country-specific delivery. Lagos and Casablanca are not the same problem, and we do not price them as though they were.
Entry decisions are not made in one motion. Each phase carries its own deliverable and its own fee, so the commitment stays proportionate to the decision in front of you.
01 · 2 to 3 weeks
Market potential, regulatory landscape, and a structured assessment of where the entry thesis holds and where it is exposed. Often enough on its own to confirm a direction or kill it.
02 · 4 to 6 weeks
Entry mode, partner approach, and an action plan with milestones and clear lines of accountability. The deliverable a board can approve and a team can execute against.
03 · 2 to 3 months
Strategy through the first phase of execution: partner selection, regulatory milestones and project steering, to close the gap between board approval and ground conditions.
04 · ongoing
Independent counsel at board and executive-committee level on market exposure and growth strategy, for operators who want a senior advisor on call through the cycle.
Delivery is on site and remote, and every engagement is confidential. The phases are sequential by design but not obligatory in sequence — most clients begin with a feasibility review or a strategy phase, depending on how far the internal thinking has run.
Most advisors frame Africa entry as opportunity sizing. We frame it as governance, because the demographics are not the constraint and execution is where capital is lost.
That framing comes from having operated, not only advised. DJC is led by a principal who founded and ran a German multinational’s operating company in Nigeria, led marketing and sales for West and Central Africa from Accra, and steered cross-border country projects across the Greater Middle East and Africa region.
The work draws on direct experience of the partner ecosystems, regulators and operating conditions that desk-research strategies routinely underprice.
The work spans founding operating leadership, regional coordination, and advisory diagnostics delivered through the firm.
Chemicals and pharmaceuticals · Nigeria · market entry and company build
Founding Managing Director of the operating company: legal entity, governance and reporting lines, finance, HR and compliance functions, and the commercial organization across four business lines, with personal statutory responsibility and representation to government and regulators. It became the group’s reference structure for the region.
Water chemicals · Africa · market entry diagnostic
A market deep-dive across African markets, sizing the opportunity by segment and country and building a decision matrix that weighed market attractiveness against the practical conditions of entry. The client gained a defensible basis for choosing where to focus, and for ruling markets out before committing capital.
Polymers and chemicals · Nigeria, Ghana, Côte d’Ivoire · distribution
Distributor network built across three countries — identification, evaluation and onboarding of partners — with the regional stock and logistics model behind it. The result was a working multi-country route to market serving three business lines and around €15 million in regional turnover.
Cases are anonymized. Full credentials are on the leadership page; further cases on the experience page.
The frameworks behind this practice: the five realities that decide an entry, and the drift that opens between board approval and the first operating quarter.
For many organizations, Africa market entry begins with a robust strategy, a compelling growth case, and full board approval. Yet months, or years, later, progress on the ground often feels slower and more fragile than anticipated.
Africa remains the boardroom’s preferred next growth story. The demographics hold, demand is rising, and the long-term fundamentals are sound. Yet most initiatives underperform, stall, or quietly exit.
A board-level read on the Nigerian refining and petrochemical sector, and what it means for international chemicals, energy and industrial-gas companies weighing an Africa play.
Contact
Bring us the assumptions the board approved. A short review will show which of them survive country-level evidence, and which need to change before capital moves.
